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ABSTRACT: The common fragile site at 3p14(FRA3B) is cytogenetically close to the positions of 
translocation and deletion breakpoints frequently observed in renal cell carcinoma (RCC) and 
small cell carcinoma ~ff the lung. Possible involvement of this fragile site in the familial RCC 
t(3;8)(p14.2;q24.1} was investigated. Expression of FRA3B, induced by treatment of lympho- 
cytes with aphidicolin, is altered by the translocation. These results suggest that the fragile 
site is very close to, if not coincident with, the translocatian breakpoint. 
INTRODUCTION 
C o m m o n  fragile  s i tes  h a v e  b e e n  o b s e r v e d  in p e r i p h e r a l  b lood  l y m p h o c y t e s  c u l t u r e d  
e i t he r  u n d e r  c o n d i t i o n s  c a u s i n g  t h y m i d y l a t e  s t ress  or w i t h  d rugs  t ha t  i n h i b i t  DNA 
r e p l i c a t i o n  or r e p a i r  [1 6]. A l t h o u g h  the  rare  fragi le  s i te  at Xq27 has  b e e n  a s s o c i a t e d  
w i t h  X - l i n k e d  m e n t a l  r e t a r d a t i o n ,  the  b io log ica l  s i gn i f i cance  of c o m m o n  fragi le  s i tes  
ha s  yet  to be  d e t e r m i n e d  [7]. T h e  s u g g e s t i o n  has  b e e n  m a d e  tha t  t he se  are s i tes  tha t  
p r e d i s p o s e  to c h r o m o s o m a l  b reakage  a n d  r e a r r a n g e m e n t s  cha r ac t e r i s t i c  of ce r t a in  
n e o p l a s i a s  [6-12] .  T he  mos t  r e ad i l y  i n d u c e d  c o m m o n  fragi le  s i te  occu r s  in b a n d  
3p14(FRA3B) ,  a r eg ion  t h a t  has  b e e n  a s s o c i a t e d  w i th  d e l e t i o n s  in  sma l l  cell  carci-  
n o m a  (SCC) of t he  l u n g  a n d  b o t h  t r a n s l o c a t i o n s  a n d  d e l e t i o n s  in  rena l  cell  carci-  
n o m a  (RCC) [13-17] .  
The  a p p a r e n t  c o i n c i d e n c e  of FRA3B a n d  the se  t r a n s l o c a t i o n  or d e l e t i o n  break-  
p o i n t s  led us to e x a m i n e  fragi le  s i te  e x p r e s s i o n  in  cel ls  f rom two  m e m b e r s  of a 
f ami ly  in  w h i c h  the  c o n s t i t u t i o n a l  t (3 ;8)(p14.2;q24.1)  segregates  w i t h  a grea t ly  in- 
c r eased  r i sk  for RCC [16]. A p h i d i c o l i n ,  an  i n h i b i t o r  of DNA p o l y m e r a s e  c~, was  used  
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to induce fragile site expression in PHA-stimulated peripheral blood lymphocytes. 
These studies demonstrated fragile site expression at the translocation breakpoint 
in both the derivative chromosome #3 and derivative #8, despite the fact that there 
is not normally a highly expressing common fragile site at 8q24. This observation 
suggests that FRA3B expression has been affected in some way by the translocation 
event. 
M E T H O D S  
Heparinized venous blood was obtained from two members (designated 9542 and 
9944) of the RCC family, both of whom carried the t(3;8)(p14.2:q24.1) [16]. Whole 
blood was cultured at 37C for 96 hours in RPMI 1640 medium containing folic acid 
(FA +) {lrvine Scientific) plus 10% fetal bovine serum (Hy-Clone, Sterile Systems, 
Inc.), or RPMI 1640 without  folio acid (FA ) with 5% fetal bovine serum. All me- 
dia were supplemented witb 2 mM glutamine, phytohemagglutinin,  and penicil l in/  
streptomycin. Aphidicol in  (dissolved in dimethylsulfoxide) was added directly to 
the cultures to a final concentration of 0.2 ~M, 26 hours before harvest. 
(;ells were scored blindly for chromosome aberrations without knowledge of 
treatment. Air-dried slides were banded with CMA2S [N,N bis-(6-chloro-2-methox- 
yacridin-9-yl) sperminel,  which has a very slow quenching rate and allows ample 
time for specific location of breakpoints [18]. Analysis was performed by two in- 
dependent  observers and results were totaled. 
R E S U L T S  
Cells were cultured in medium with or without folio acid and with or without 0.2 
IzM aphidicolin.  Fragile site expression was scored for normal chromosomes #3 
and #8, together with the reciprocal derivative chromosomes generated by the 
translocation. The results presented in Table 1 demonstrate the expression of 
FRA3B. The fragile site was observed on the normal #3, as expected. It was ob- 
served not only on the deriw~tive #3 chromosome, but also on the derivative #8 at 
or near the translocation breakpoints. Figure 1 shows an example of a metaphase in 
which fragile sites on the normal #3, derivative #3, and derivative #8 are simul- 
taneously expressed. Table 1 shows that there is less expression of the fragile site 
in each of the derivative chromosomes relative to the normal #3. When the data 
for the derivative chromosomes are combined, however,  the numbers approximate 
that seen in the normal #3, except in one case (9542, F A + ,  0.2 btM aphidicolin),  
where the sum of the breaks in the derivative chromosomes was only half of that 
seen in the normal #3. 
Table 1 FRA3B Expression in t(3;8)(p14.2;q24.1) lymphocytes 
Breaks or gaps/cells 
Normal, Normal, 
Subject Medium Aphidicolin [~,M) 3p14 8q24 der3p14 der8q24 
9542 FA + 0 1/25 0/25 0/25 0/25 
FA ~ 0.2 20/75 1/75 2/75 7/75 
FA U 3,'25 0/25 0725 0/25 
FA 0.2 19/50 0/50 5/50 7/50 
9944 FA + 0 0/50 0/50 0/50 O/50 
FA + 0.2 18/73 0/73 5/73 15/73 
t(3;8)(p14.2;q24.1) in RCC 7 1  
Figure  1 A representative Q-banded metaphase from 9542 after treatment with ~1.2 p,M aphi- 
dicolin for 26 hours. Arrows mark the, expresse.d fragile site in the normal #3, der{3), and 
der(8). The normal #8, with no visible fragile site, is also marked with an arrow. In the case 
of the derivative chromosomes, the fragile site, is located at or near the translocatim~ break- 
points. 
Cul tur ing  the cel ls  in folio acid-free m e d i u m  (FA ) creates a cond i t ion  of thv- 
midy la t e  stress resu l t ing  in a low- leve l  express ion  of FRA3B and of fragile sites at 
o ther  locat ions  (data not shown) .  W h e n  aph id i co l i n  is added  to cells  grown in FA 
media ,  this express ion  is greatly enhanced .  
DISCUSSION 
FRA3B is the most  read i ly  induc ib l e  of the apb id i co l i n - s ens i t i ve  fragile sites in 
l y m p h o c y t e s  [5]. The  ex i s tence  of a cons t i tu t iona l  t rans loca t ion  with  one break- 
poin t  at 3p14.2 p r o v i d e d  an o p p o r t u n i t y  to s tudy the effect of this rea r rangement  
oi1 FRA3B express ion .  The  aberra t ions  that can be seen at the t rans locat ion  break- 
points  suggest that  the t rans loca t ion  has a l tered the express ion  of FRA3B. There  are 
at least six events  that cou ld  have  led to this  observat ion .  FRA3B could  have  been 
spli t  by the  t rans loca t ion  or pe rhaps  dup l ica ted .  It is also possible  that there are 
two fragile sites in band 3p14.2 and the t rans loca t ion  broke be tween  the sites. Al- 
ternat ively ,  the t rans loca t ion  cou ld  have  genera ted  an a l together  n e w  fragile site or, 
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by coincidence, a previously undescribed rare fragile site could be present at 8q24 
in this family. Finally, we could have observed a greatly enhanced expression of a 
constitutive fragile site reported to be present at 8q24.1 [6]. This is unlikely, how- 
ever, because this fragile site has not been observed, except in an occasional cell, 
in our laboratories using the culture condit ions described here. The numbers  in 
Table 1 favor the hypothesis that FRA3B has been split by the translocation and 
make it unl ikely that it has been duplicated. If the fragile site is an amplified se- 
quence, as has been suggested for the fragile X [19, 20], this would be possible. 
Regardless of the event that caused the appearance of weakly expressing sites on 
the derivative #3 and derivative #8 chromosomes, the results strongly suggest that 
the translocation breakpoint and FRA3B are very close to one another and possibly 
coincident.  
The oncogene myc  has been mapped to 8q24.1, the location of the chromosome 
#8 breakpoint in these cells. This fact suggests that myc  could be involved in the 
development  of cancer in this family. It has been shown by somatic cell hybridiza- 
tion that m yc  has been moved to the derivative #3 chromosome; however, South- 
ern blot hybridization has failed to reveal any molecular rearrangement of myc in 
this instance [21]. Furthermore, we have used pulsed field gel electrophoresis to 
construct a map that covers a 1500-kb region surrounding m yc  and have been un- 
able to detect the translocation breakpoint [22]. Of the cytogenetic rearrangements 
seen in RCC, 3p14 is more consistently involved than 8q24 [17]. These observations 
do not support a primary role for the myc  oncogene in RCC. 
Although the role of fragile sites in the development of cancer is unclear, the 
observation has been made that the breakpoints of certain cancer rearrangements 
are cytogenetically located at or near fragile sites [6-12]. Some have suggested that 
this is merely a coincidence [23], whereas, others suggest the possibility of a direct 
causal relationship [6, 8-11]. The observation that FRA3B is in close proximity to 
the t(3;8)(p14.2;q24.1) breakpoint makes it tempting to speculate that this particular 
fragile site may have had a causal role in the generation of this translocation or at 
least by coincidence is right at the translocation breakpoint. Further experimenta- 
tion is necessary before this speculation can be confirmed. 
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